Chronic dyspnea, defined as persistent or progressive shortness of breath, is a common symptom in patients with chronic respiratory, cardiovascular, or neuromuscular conditions and significantly impacts quality of life. Chronic dyspnea management involves a comprehensive approach aimed at relieving symptoms, improving functional capacity, and enhancing daily living activities. Assessment begins with identifying underlying causes, evaluating pulmonary and cardiac function, and reviewing comorbidities that may exacerbate breathlessness. Interventions may include pharmacological therapies, such as bronchodilators, anti-inflammatory agents, or cardiovascular medications, alongside non-pharmacological strategies like pulmonary rehabilitation, breathing exercises, and physical conditioning to strengthen respiratory muscles. Chronic dyspnea management also emphasizes patient education on energy conservation, pacing techniques, and strategies to recognize early signs of exacerbation. Supplemental oxygen and ventilatory support may be indicated for patients with severe or refractory symptoms, while multidisciplinary collaboration among pulmonologists, physiotherapists, nutritionists, and mental health professionals ensures a holistic approach. Recent research highlights the value of integrative therapies, including mindfulness, relaxation techniques, and structured exercise programs, in reducing anxiety and improving symptom perception. Continuous monitoring and adjustment of treatment plans are critical for achieving sustained relief and preventing hospitalizations. By combining targeted medical interventions, lifestyle modifications, and patient-centered education, chronic dyspnea management enhances respiratory efficiency, quality of life, and overall functional independence in individuals affected by long-term respiratory compromise.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation